347 related articles for article (PubMed ID: 31213179)
1. Antithrombin supplementation in adult patients receiving extracorporeal membrane oxygenation.
Morrisette MJ; Zomp-Wiebe A; Bidwell KL; Dunn SP; Gelvin MG; Money DT; Palkimas S
Perfusion; 2020 Jan; 35(1):66-72. PubMed ID: 31213179
[TBL] [Abstract][Full Text] [Related]
2. A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation.
Panigada M; Cucino A; Spinelli E; Occhipinti G; Panarello G; Novembrino C; Consonni D; Protti A; Lissoni A; Arcadipane A; Pesenti A; Grasselli G
Crit Care Med; 2020 Nov; 48(11):1636-1644. PubMed ID: 32947474
[TBL] [Abstract][Full Text] [Related]
3. Exogenous supplementation of antithrombin III in adult and pediatric patients receiving extracorporeal membrane oxygenation.
Sorial MN; Greene RA; Zullo AR; Berard-Collins C; Willis S
Int J Artif Organs; 2020 May; 43(5):315-322. PubMed ID: 31750755
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
[TBL] [Abstract][Full Text] [Related]
5. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
6. Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation.
Deatrick KB; Galvagno SM; Mazzeffi MA; Kaczoroswki DJ; Herr DL; Rector R; Hochberg E; Rabinowitz RP; Scalea TM; Menaker J
Perfusion; 2020 Jan; 35(1):13-18. PubMed ID: 31122144
[TBL] [Abstract][Full Text] [Related]
7. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
[TBL] [Abstract][Full Text] [Related]
8. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
Krueger K; Schmutz A; Zieger B; Kalbhenn J
Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin Levels and Heparin Responsiveness during Venoarterial Extracorporeal Membrane Oxygenation: A Prospective Single-center Cohort Study.
Mansour A; Berahou M; Odot J; Pontis A; Parasido A; Reizine F; Launey Y; Garlantézec R; Flecher E; Lecompte T; Nesseler N; Gouin-Thibault I
Anesthesiology; 2024 Jun; 140(6):1153-1164. PubMed ID: 38271619
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin III supplementation on extracorporeal membrane oxygenation: impact on heparin dose and circuit life.
Byrnes JW; Swearingen CJ; Prodhan P; Fiser R; Dyamenahalli U
ASAIO J; 2014; 60(1):57-62. PubMed ID: 24296776
[TBL] [Abstract][Full Text] [Related]
11. Conventional versus restricted anti-Xa-guided heparin protocol in adult patients undergoing extracorporeal membrane oxygenation.
Alkazemi A; Eche IM; Adra M; Cabezas F; Patel P; Rick K; Grandin EW
Artif Organs; 2022 Jan; 46(1):128-137. PubMed ID: 34725832
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin concentrates use in children on extracorporeal membrane oxygenation: a retrospective cohort study.
Wong TE; Delaney M; Gernsheimer T; Matthews DC; Brogan TV; Mazor R; McMullan DM; Reiner AP; Konkle BA
Pediatr Crit Care Med; 2015 Mar; 16(3):264-9. PubMed ID: 25581634
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Antithrombin III Products in Pediatric Patients Receiving Extracorporeal Membrane Oxygenation.
Omecene NE; Kishk OA; Lardieri AB; Walker LK; Bhutta AT
ASAIO J; 2020; 66(9):1042-1047. PubMed ID: 31977357
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation Management and Antithrombin Supplementation Practice during Veno-venous Extracorporeal Membrane Oxygenation: A Worldwide Survey.
Protti A; Iapichino GE; Di Nardo M; Panigada M; Gattinoni L
Anesthesiology; 2020 Mar; 132(3):562-570. PubMed ID: 31764152
[TBL] [Abstract][Full Text] [Related]
15. Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: a retrospective pediatric study.
Irby K; Swearingen C; Byrnes J; Bryant J; Prodhan P; Fiser R
Pediatr Crit Care Med; 2014 May; 15(4):e175-82. PubMed ID: 24622165
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin use during pediatric cardiac extracorporeal membrane oxygenation admission: insights from a national database.
Aiello SR; Flores S; Coughlin M; Villarreal EG; Loomba RS
Perfusion; 2021 Mar; 36(2):138-145. PubMed ID: 32650697
[TBL] [Abstract][Full Text] [Related]
17. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P
J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330
[TBL] [Abstract][Full Text] [Related]
18. Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.
O'Meara LC; Alten JA; Goldberg KG; Timpa JG; Phillips J; Laney D; Borasino S
ASAIO J; 2015; 61(3):339-44. PubMed ID: 25710768
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin Concentrate Use in Pediatric Extracorporeal Membrane Oxygenation: A Multicenter Cohort Study.
Wong TE; Nguyen T; Shah SS; Brogan TV; Witmer CM
Pediatr Crit Care Med; 2016 Dec; 17(12):1170-1178. PubMed ID: 27662567
[TBL] [Abstract][Full Text] [Related]
20. A narrative review of antithrombin use during veno-venous extracorporeal membrane oxygenation in adults: rationale, current use, effects on anticoagulation, and outcomes.
Piacente C; Martucci G; Miceli V; Pavone G; Papeo A; Occhipinti G; Panarello G; Lorusso R; Tanaka K; Arcadipane A
Perfusion; 2020 Sep; 35(6):452-464. PubMed ID: 32228213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
